Back to Search
Start Over
Ashland injectable pharmaceutical excipient accepted into FDA Novel Excipient Review Pilot Program
- Source :
- Plus Company Updates. November 1, 2022
- Publication Year :
- 2022
-
Abstract
- WILMINGTON, Del: Ashland, Inc. has issued the following news release: Ashland Inc. (NYSE: ASH) today announced the United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.725634162